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Abstract 
Background: Presentation of case reviews depicting the imaging characteristics of carotid 
paragangliomas, associated with a thorough analysis of the anatomical morphological 
features and the current therapeutic strategies. 
Methods: We present the cases of three patients diagnosed with carotid paragangliomas in 
our clinic, illustrating diagnostic imaging elements by computer tomography (CT) and 
magnetic resonance imaging (MRI), but also the postoperative aspect of the carotid system, 
with respective anatomical, clinical and surgical considerations.  
Results: The imaging aspect of the carotid paragangliomas is characterized by a mass of 
soft tissue with intense contrast enhancement and with “salt and pepper" MRI appearance 
on conventional spin-echo sequences. The postoperative evolution of the patients included 
in the article was favorable, without any perioperative complications or signs of local tumor 
recurrence. 
Conclusions: Carotid paragangliomas are rare, often asymptomatic tumors, but with 
potential for increased malignancy, which raises the need for good knowledge of the 
cervical region pathology as well as the features of neuroendocrine tumors. CT and MRI 
examinations are essential for diagnosis, staging and, implicitly, for establishing the 
therapeutic strategy. 
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imaging, therapeutic strategy 
 
 
Introduction 
Carotid paragangliomas (CPs), also known as carotid body tumors, are 
neuroendocrine tumors originating in the parenchymal cells of the neuroectoderm and 
neural crests, but also in the mesodermal elements of the third branchial arch [1, 17, 19, 28, 
30]. Thus, the cells that make up paragangliomas are similar to the cells in the APUD 
(amine precursor uptake and decarboxylation) system and can release catecholamines, 
cholecystokinin, serotonin, somatostatin, and vasoactive intestinal peptide [20]. 
Paragangliomas have variable localization and may develop in the head, neck, 
thorax, or abdomen. Head and neck paragangliomas can show the following topography: 
carotid (carotid glomus), tympanic (glomus tympani), jugular (glomus jugulare) or vagal 
(glomus vagale) [22]. These tumors are rare [1, 26, 30], can be single or multifocal tumors, 
and are considered benign but with malignant potential in 6-12% of cases [14, 19, 28, 34]. 
CPs represent 0.6% of head and neck neoplasms, accounting for 60-70% of paragangliomas 
of the head and neck region, and make up 0.5% of tumors affecting the entire body [1, 14, 
34]. 
The majority of paragangliomas are sporadic, however, in about 40% of cases, 
family history is demonstrated [5]. Hereditary tumors are more often multicentric and tend 
to occur earlier than sporadic forms, with a peak incidence at 30-35 years of age [18]. 
Familial paragangliomas exhibit autosomal dominant transmission and are commonly seen 
in patients with von Hippel-Lindau disease, type I neurofibromatosis, and type II multiple 
endocrine neoplasias [23]. 
The scope of this paper is to mark the essential diagnostic elements of carotid 
paragangliomas useful to the clinicians and surgeons in planning the therapeutic strategy. 
Starting from the presentation of three illustrative cases investigated in our clinic, we 
analyzed the specific literature data and detailed the most important elements involved in 
the management of these tumor types. 
Case reports 
Case 1. A 42-year-old woman was admitted to the hospital for a painless left 
cervical tumor measuring close to 3 cm, with a soft consistency, and mobile in the 
transverse plane. The ultrasound showed a submandibular hypoechogenic mass that 
displaced the internal carotid artery. The MRI examination revealed a hypervascular lesion 
with a "salt and pepper" appearance located in the left carotid space, at the terminal 
bifurcation of the common carotid artery, with suggestive characteristics for CP (Figure 1). 
The patient refused surgery, but 90 days later she returned determined to receive treatment. 
CT angiography confirmed a bright and rapidly enhancing mass located at the level of the 
left carotid bifurcation compatible with a diagnosis of a type II Shamblin CP (Figure 2). 
The chosen treatment course implied the surgical cure of the tumor with a favorable 
postoperative evolution, without incidents, and with no detectable tumor recurrence on 
imaging follow-up at 3 months and, subsequently, at 6 and 12 months. 
Case 2. A 55-year-old woman with no particular pathological background was 
admitted with a right cervical mass showing slow dimensional progression within a year, 
with no other associated symptoms. The clinical examination and ultrasound confirmed the 
presence of a tumor with soft consistency adjacent to the right internal carotid artery. The 
MRI and CT examinations revealed a type IIIa Shamblin CP, with a characteristic "salt and 
pepper" appearance at the level of the right carotid bifurcation, with a small extension to 
the submandibular space and the right postero-lateral wall of the pharynx (Figure 3). The 
patient showed favorable postoperative evolution with a good evolution and is periodically 
evaluated in our clinic, without complications or tumor recurrence at 3.5 years after 
surgery. 
Case 3. A diabetic 46-year-old woman presented with a left-cervical mass 
manifested in the last two years, with a gradual increase in size and associating dysphonia 
at the time of hospitalization. The ultrasound examination suspected a CP by highlighting a 
hypoechogenic mass at the carotid bifurcation, which splays the external and internal 
carotid arteries, extending medially to the retropharyngeal space, anteriorly to the 
submandibular branch, and posteriorly through the soft prevertebral tissues. CT 
angiography established the diagnosis of a type IIIb Shamblin CP (Figure 4). No incidents 
occurred during the surgical procedure and intraoperative observations confirmed the 
inclusion and infiltration of the internal carotid artery. The follow-up examinations 
performed at 3 and 12 months did not reveal any complications or local tumor recurrence. 
Imaging review of paragangliomas 
Imaging is an essential part of the diagnostic protocol in the management of carotid 
glomus tumors. CT and MRI examinations using contrast mediums are useful in lesion 
detection, thus obtaining valuable information regarding the lesion size, the relationship 
with the adjacent anatomical structures, and the degree of vascularization. Additionally, 
blood flow downstream of the lesion can be ascertained, and the presence of collateral 
circulation, anatomic variants, and other synchronous paragangliomas in other regions of 
the body can also be demonstrated [33]. 
Ultrasonography (US) is a first-line imaging method for determining the location 
and features of lateral-cervical masses. CP appears as a well-delimited round-oval 
hypoechogenic mass located at the level of the carotid sinus, causing the carotid bifurcation 
to flare. Color Doppler or Doppler Duplex highlights the hypervascular character of the 
lesion and allows differentiation from other tumors, but with limited possibilities in 
detecting local invasion [15]. 
Computed Tomography (CT) shows CP as a soft tissue mass located in the carotid 
space, with intense and homogeneous early enhancement due to its highly vascular nature. 
Large tumors may exhibit a heterogeneous structure due to the presence of thrombi or focal 
hemorrhages. Flaring (splaying) of the external and internal carotid arteries, a hallmark of 
PC, can also be easily visualized on CT (Figure 5). Irradiation and the allergic risk to the 
iodinated contrast substance are the main disadvantages of CT [32]. 
Magnetic Resonance Imaging (MRI) has proven its superiority to other imaging 
techniques in offering a more accurate appreciation of lesion margins and invasion of 
adjacent structures [24]. Using native and contrast-enhanced spin-echo sequences with fat 
suppression, MRI examination can determine vascular invasion more accurately compared 
to CT, and can also provide more detailed vascular morphometry measurements [9]; 
additionally, MRI and can reveal lesions smaller than 5 mm, while CT usually depicts 
lesions larger than 8 mm [31]. The typical MRI aspect of CP is given by the presence of 
multiple punctiform or serpentine shaped intralesional foci with signal void. These are 
caused by the higher flow velocity in the intratumoral vessels and give the whole lesion a 
"salt and pepper" appearance (Figure 6). The "salt" represents areas of hyperintensities due 
to slow vascular flow or microhemorrhages, while the "pepper" corresponds to the above-
mentioned areas with markedly decreased T1 and T2 signals (signal void) [15]. This 
imaging pattern is rarely found in lesions larger than 1 cm, and can also be observed in 
other hypervascular tumors such as renal cell carcinoma metastases and thyroid carcinoma 
metastases [12]. 
Conventional digital subtraction angiography is the gold standard for evaluating the 
vascular architecture of these tumors. The typical angiographic aspect of paragangliomas is 
that of a hypervascular mass which splays the internal and external carotid arteries and 
presents large feeding arteries, intense arterial flash, and quick contrast washout. The 
tributary arteries of CPs are the ascending pharyngeal artery and the ascending cervical 
artery. As the tumor increases in size, contributions from other arterial sources such as the 
facial, lingual, or thyroid arteries may add up. It is mandatory to note the patency of the 
internal jugular vein, which may be thrombosed in large CPs [6].  
Differential imaging diagnosis of paragangliomas should include nerve sheath 
tumors that displace the carotid arteries medially and anteriorly while the internal jugular 
vein is pushed posteriorly, as compared to CPs that splay the carotids; other diagnoses 
include vagal glomus tumors which display similar morphological characteristics but are 
more rostrally located, and also hypervascular metastatic adenopathies from renal or 
thyroid malignancies, which are difficult to distinguish from CPs [6, 32]. Histopathology is 
not necessary for the diagnosis and performing a biopsy may even be very dangerous due to 
the high degree of tumor vascularization [21, 29]. 
Discussions 
Carotid paragangliomas generally affect women [1, 19, 28, 30, 34], are bilateral in 
about 10% of cases [6], and the involvement of hereditary factors is described in 4-9% of 
cases [28, 30, 34]. 
From a clinical standpoint, CP are slow-evolving tumors which may remain 
painless and generally asymptomatic and for a long period of time, and are located 
anteriorly to the lateral sternocleidomastoid muscle, showing mobility in the lateral plane, 
but fixed in the cephalocaudal plane (Fontaine's sign) [31]. CPs significantly alter the loco-
regional anatomy, both through their dimensions and their position. Therefore, any lesion 
that develops adjacent to the terminal bifurcation of the common carotid artery will induce 
changes in the muscular, vascular, and nervous anatomical relations. Taking into account 
the vascular nature of the lesion in question, the most apparent altered index could be the 
angle between the origins of the internal and external carotid arteries. As carotid body 
tumors grow in size they can invade the parapharyngeal space causing a bulging of the 
lateral oropharyngeal wall inducing dysphagia, odynophagia, or syndromes associated with 
cranial nerves IX-XII disorders [35]. 
Carotid body tumors are paragangliomas that show high malignant capacity, a 
feature that occurs in 6-12% of cases [14, 19, 28, 34]. In the absence of specific 
histopathological criteria, malignancy is marked by the anatomical presence of metastases 
[10], with a predilection for regional lymph nodes, and very rare distant metastases [3]. The 
therapeutic method of choice for carotid body tumors is surgical removal, which in select 
cases may be preceded by angiographic embolization [8, 25]. Embolization may reduce the 
size of the tumor and promote its disconnection from the vascular system, thereby reducing 
intraoperative bleeding [13, 36]. Among the significant complications of surgical treatment 
are secondary bleeding, cranial nerve deficiency, and perioperative stroke; therefore, the 
intervention requires caution in aged patients, especially in patients with cardio-ischemic 
pathology despite the general addressability of the surgery [7, 8, 13, 25, 36].  
The key element in choosing the right therapeutic conduit is the assessment of the 
extent of tumoral vascular involvement through medical imaging, a method that also 
provides insight regarding the prognosis and possible complications. As such, a 
classification system for CP was proposed by Shamblin and collaborators in 1971 and is 
currently in use despite its shortcomings regarding the degree of tumor infiltration into the 
carotid wall, a critical element to be factored when the preservation of the arteries is 
considered. According to Shamblin, type I tumors are located at the bifurcation of the 
common carotid artery, with minimal contact area with blood vessels, type II encompasses 
tumors that have a diameter generally less than 5 cm, and include about 50% of the 
circumference of the main arterial axis, entailing difficulties for the surgical cure, while 
type III is reserved for generally large tumors with a diameter greater than 5 cm, that 
completely enclose the main arterial axis [27]. 
Luna-Ortiz emphasizes that imaging by axial sections does not accurately 
approximate the carotid wall tumor infiltration preoperatively, but it highlights the 
circumferential ratio of the tumor to the adjacent vascular structures. Thus, in 2006, Luna-
Ortiz and collaborators proposed the introduction of a grade IIIb to the carotid 
paragangliomas, which, regardless of their size, infiltrate the carotid wall. According to 
Luna-Ortiz, type IIIa is superimposed on the old (Shamblin) type III, respectively CPs that 
include the vessels without infiltrating them [16]. 
A study by Arya et al. sustains a good correlation between the radiological aspects 
of the Shamblin classification and surgical results, and concludes that without taking into 
account the tumor size, the maximum degree of circumferential tumor/artery contact should 
be the only criterion for the Shamblin classification, therefore predicting the degree of 
vascular viability [2]. 
Radiation therapy, alone or associated with surgery, is another therapeutic strategy 
that can be chosen in the case of carotid glomus tumors. The treatment is based on the 
induction of local fibrosis, which can stop tumor development and is indicated in 
inoperable cases or postoperative relapses [4, 11]. 
Conclusions 
Carotid paragangliomas are hypervascular tumors, with imaging features of a soft 
tissue mass with intense enhancement and “salt and pepper” appearance on MRI in 
conventional spin-echo sequences. 
The radiological examination is essential for diagnosis and the establishing of the 
therapeutic strategy. Firstly, the tumor must be detected and characterized, and secondly, 
the lesion extension must be appreciated in regard to the surrounding vascular structures. 
Last but not least, the presence of concomitant tumors should be verified, considering that 
paragangliomas are multifocal lesions in 30% of patients. 
Considering all the information presented, the medical team managing a CP case 
should benefit from a mindful preoperative planning and a correct selection of patients, in 
order to obtain a successful therapeutic result. 
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Figure 1. MRI investigation consisting of (a) coronal Short Tau Inversion Recovery 
(STIR), (b) axial T2 fat-saturated WI, (c) sagittal T1 WI, and (d) gadolinium-enhanced 
axial T1 fat-saturated images depicting a inhomogeneous oval solid mass (star) with 
intermediate signal on T1WI and high signal on T2WI, intralesional foci in signal void that 
create an overall "salt and pepper" appearance, developed at the level of left carotid 
bifurcation; the lesion shows intense early enhancement, widens the angle of bifurcation of 
the common carotid artery and spreads the left external (ECA) and internal (ICA) carotid 
arteries, without altering their permeability and rapid blood flow signal. 
 
Figure 2. CT examination: (a) axial CT angiography, (b) coronal-oblique maximum-
intensity-projection (MIP) reformatted image, (c) curved-planar reformatted image of the 
left internal carotid artery, and (d) 3-D volume-rendered reformatted image. Large solid 
mass (star), with intense and slightly inhomogeneous enhancement, located at the level of 
the left carotid bifurcation, separating the external carotid (ECA) and internal carotid (ICA) 
arteries. The described lesion encases about 50% of the circumference of the internal 
carotid artery, without modifying its lumen (type II Shamblin) and is adjacent to the 
internal jugular vein (IJV). Macroscopic appearance (e) of the carotid body tumor after 
complete excision with a pseudo capsule (black arrow) and multiple feeding vessels 
(orange arrow). Microscopic specimen (f): uniform polygonal cells with abundant 
eosinophilic granular cytoplasm and large, regular, central nuclei. 
 
Figure 3. MRI saturated T2 axial fat image (a) and gadolinium-enhanced T1 fat axial 
image (b), and axial CT postcontrast-arterial phase (c) showing a solid mass (star) with 
well-defined contour, inhomogeneous signal, "salt and pepper" aspect, and intense early 
contrast enhancement, located at the level of the right carotid bifurcation, separating the 
right internal (ICA) and external (ECA) carotid arteries. The lesion splays the carotid 
arteries, encloses the ICA and ECA without infiltrating them. Intraoperative view of the 
carotid body tumor before complete excision (d). 
 
Figure 4. CT-angiography coronal-oblique volume-rendered images pre (a), (b), and 
postoperatively (c) highlighting a large hypervascular mass (star) at the level of the left 
carotid bifurcation that splays the carotid arteries and infiltrates the internal carotid wall, 
correspondingly to a type IIIb Shamblin tumor. Imaging performed one year after surgery 
demonstrates the absence of recurrence and normal appearance of the left carotid arteries. 
Intraoperative appearance of the carotid body tumor (d). Gross pathology specimen with a 
meaty appearance with a bulging surface (e). Photomicrograph of the histologic specimen 
(HE, x400) showing highly vascularized fibrous septa surrounding the chief neoplastic cells 
(f). 
 
Figure 5. Contrast-enhanced CT: axial images (a) and coronal-oblique MIP (b) showing a 
widening of the distance between the left carotid arteries (black arrow) as a result of the 
development of a carotid body tumor (star). Left side vessels are marked: vertebral (VA), 
common carotid (CCA), internal carotid (ICA) and external carotid (ECA) arteries. 
 
Figure 6. MRI aspect of a carotid body tumor with “salt and pepper” sign generated by 
signal void areas due to numerous intratumoral vessels (arrowheads); (a) T1 WI, (b) T2FS 
WI, (c) short tau inversion recovery (STIR) images. 






